## BDX: Becton, Dickinson and Company - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -2.6% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($181.76)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Arrowstreet Capital Limited Partnership Buys New Shares in Becton, Dickinson and Company $BDX**
- Source: MarketBeat | 20251207T010924 | Somewhat-Bullish | Relevance: 99%
-  Arrowstreet Capital Limited Partnership acquired a new position of 197,345 shares in Becton, Dickinson & Company (NYSE:BDX) during Q2, valued at approximately $33.99 million. Other institutional investors also adjusted their holdings in BDX, which currently has a "Hold" consensus rating from analysts with a price target of $204.45. Becton, Dickinson and Company also increased its quarterly dividend to $1.05 per share, resulting in an annualized dividend of $4.20.

**2. Jump Financial LLC Raises Holdings in Becton, Dickinson and Company $BDX**
- Source: MarketBeat | 20251208T114458 | Somewhat-Bullish | Relevance: 99%
-  Jump Financial LLC significantly increased its stake in Becton, Dickinson and Company (NYSE:BDX) by 4,548.6% in the second quarter, bringing its total holdings to 65,173 shares valued at $11,226,000. Other institutional investors also adjusted their positions, and the company recently declared a quarterly dividend of $1.05 per share. Analysts generally hold a "Hold" rating on BDX with a consensus price target of $204.45.

**3. Guggenheim Capital LLC Raises Holdings in Becton, Dickinson and Company $BDX**
- Source: MarketBeat | 20251206T180720 | Somewhat-Bullish | Relevance: 98%
-  Guggenheim Capital LLC increased its stake in Becton, Dickinson and Company (NYSE:BDX) by 13.9% in the second quarter, now holding 61,229 shares valued at $10.55 million. The company announced a dividend increase to $1.05 per share, representing an annualized dividend of $4.20 and a 2.2% yield. BDX currently has a "Hold" consensus rating from analysts with an average price target of $204.45.

**4. Panagora Asset Management Inc. Sells 229,712 Shares of Becton, Dickinson and Company $BDX**
- Source: MarketBeat | 20251207T100720 | Neutral | Relevance: 98%
-  Panagora Asset Management Inc. significantly reduced its stake in Becton, Dickinson and Company (NYSE:BDX) by 99.0% in the second quarter, selling 229,712 shares and retaining 2,295 shares worth approximately $395,000. Despite this sell-off, institutional investors collectively own 86.97% of BDX shares. Becton, Dickinson recently increased its quarterly dividend to $1.05 and has a consensus "Hold" rating from brokerages with an average price target of $204.45.

**5. First Trust Advisors LP Has $47.38 Million Position in Becton, Dickinson and Company $BDX**
- Source: MarketBeat | 20251209T093323 | Somewhat-Bullish | Relevance: 98%
-  First Trust Advisors LP increased its stake in Becton, Dickinson and Company (NYSE:BDX) by 6.3% during the second quarter, valuing their position at $47.38 million. Other institutional investors like Vanguard Group Inc. and T. Rowe Price Investment Management Inc. also significantly increased their holdings in the medical instruments supplier. The article also details recent insider stock sales, analyst ratings, and the company's financial performance, including a recent dividend increase.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $210 | $197 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.04M) |
| Sells | 6 ($0.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 11.4% (+0.5%)
- Blackrock Inc.: 9.7% (+1.7%)
- T. Rowe Price Invest: 5.7% (+0.3%)
- State Street Corpora: 4.9% (+3.4%)
- JPMORGAN CHASE & CO: 3.7% (+132.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.99 indicates undervaluation relative to growth. Balance sheet: $2.7B free cash flow. Analyst sentiment positive (1 raises, avg +7%). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $54.3B |
| Beta | 0.28 |
| 52W Range | $162.29 - $251.99 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.99 |
| Forward P/E | 11.9 |
| Current P/E | 12.7 |
| YoY Growth | 6.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 5.6pp (needs >3.0% for momentum thesis). Below SMA200 (0.99x), long-term trend not supportive. RSI neutral at 49.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.62% (CS: 28) | Weak |
| RSI_14 | 48.7 | Neutral |
| MACD Histogram | -0.17 | Bearish |
| vs SMA20 | 0.989x | Below |
| vs SMA50 | 1.007x | Above |
| vs SMA200 | 0.992x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $189.50
- **Stop Loss:** $181.76 (4.1% risk)
- **Target:** $197.24 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 64
- **Position Value:** $12,128.00
- **Portfolio %:** 12.13%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-09 (Est: $2.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.91 | $3.96 | +1.1% |
| 2025Q2 | $3.40 | $3.68 | +8.2% |
| 2025Q1 | $3.28 | $3.35 | +2.1% |
| 2024Q4 | $2.99 | $3.43 | +14.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*